Indwelling central venous catheter infection with Chryseobacterium shandongense – successful eradication in a 5-year-old with cystic fibrosis

Anthony Rowan, Tiarnan Fallon Verbruggen, Nuala H. O'Connell, Patrick J. Stapleton, Colum P. Dunne, Barry Linnane, Daryl Butler
{"title":"Indwelling central venous catheter infection with Chryseobacterium shandongense – successful eradication in a 5-year-old with cystic fibrosis","authors":"Anthony Rowan, Tiarnan Fallon Verbruggen, Nuala H. O'Connell, Patrick J. Stapleton, Colum P. Dunne, Barry Linnane, Daryl Butler","doi":"10.1099/acmi.0.000700.v3","DOIUrl":null,"url":null,"abstract":"\n Introduction.\n \n \n Chryseobacterium shandongense\n \n is a Gram-negative \n \n Flavobacterium\n \n bacillus with intrinsic multidrug-resistant properties.\n \n Case Presentation. Herein, we present the first case report of human \n \n C. shandongense\n \n infection, relating to an implantable portal and catheter (port-a-cath) central line in a 5-year-old female with cystic fibrosis. The infection was identified using a Bruker MALDI-TOF Biotyper with BDAL (v12) of blood, which was cultured due to pyrexia and rigour following port-a-cath access. This report details the effective eradication of \n \n C. shandongense\n \n infection from the port-a-cath device using initial empirical gentamicin followed by targeted ciprofloxacin locks and systemic antibiotics.\n \n Conclusion. We demonstrated successful eradication of \n \n C. shandongense\n \n from a port-a-cath device, including the minimum inhibitory concentrations (MICs) required in this case. The result was eradication of central access infection, preventing progression to bacteraemia/septicaemia and preserving central access in a child with cystic fibrosis and established respiratory disease.","PeriodicalId":6956,"journal":{"name":"Access Microbiology","volume":"114 15","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Access Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1099/acmi.0.000700.v3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. Chryseobacterium shandongense is a Gram-negative Flavobacterium bacillus with intrinsic multidrug-resistant properties. Case Presentation. Herein, we present the first case report of human C. shandongense infection, relating to an implantable portal and catheter (port-a-cath) central line in a 5-year-old female with cystic fibrosis. The infection was identified using a Bruker MALDI-TOF Biotyper with BDAL (v12) of blood, which was cultured due to pyrexia and rigour following port-a-cath access. This report details the effective eradication of C. shandongense infection from the port-a-cath device using initial empirical gentamicin followed by targeted ciprofloxacin locks and systemic antibiotics. Conclusion. We demonstrated successful eradication of C. shandongense from a port-a-cath device, including the minimum inhibitory concentrations (MICs) required in this case. The result was eradication of central access infection, preventing progression to bacteraemia/septicaemia and preserving central access in a child with cystic fibrosis and established respiratory disease.
留置中心静脉导管感染山东干酪杆菌--成功根除一名 5 岁囊性纤维化患者的感染
介绍。山东黄杆菌是一种具有多重耐药特性的革兰氏阴性黄杆菌。案例演示。在此,我们报告了首例人类山东C.感染病例,涉及一名患有囊性纤维化的5岁女性的植入式门脉和导管(port-a-cath)中心线。使用Bruker MALDI-TOF生物分型仪和血液BDAL (v12)对感染进行鉴定,该血液是由于静脉导管进入后的发热和僵硬而培养的。本报告详细介绍了最初使用经验庆大霉素,然后使用靶向环丙沙星锁定和全身抗生素,有效根除导管口装置中的山东产假体感染。结论。我们证明了从一个port-a-cath装置中成功根除山东C.,包括在这种情况下所需的最低抑制浓度(mic)。结果是根除中央通路感染,防止进展为菌血症/败血症,并在患有囊性纤维化和已确诊呼吸道疾病的儿童中保留中央通路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信